Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3834083)

Published in Transl Res on June 01, 2013

Authors

Maria M Gramatges1, Alison A Bertuch

Author Affiliations

1: Section of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Tex.

Articles citing this

Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest (2015) 1.16

Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Arch (2014) 1.09

Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07

Cell biology of disease: Telomeropathies: an emerging spectrum disorder. J Cell Biol (2014) 1.07

Telomere biology and translational research. Transl Res (2013) 0.90

The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med (2014) 0.86

Clinical utility gene card for: Dyskeratosis congenita - update 2015. Eur J Hum Genet (2014) 0.86

Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant (2015) 0.84

Telomere length variation: A potential new telomere biomarker for lung cancer risk. Lung Cancer (2015) 0.82

Telomere maintenance mechanisms in cancer: clinical implications. Curr Pharm Des (2014) 0.82

Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis. Haematologica (2016) 0.81

Nature vs nurture: interplay between the genetic control of telomere length and environmental factors. Cell Cycle (2013) 0.81

Involvement of Atm and Trp53 in neural cell loss due to Terf2 inactivation during mouse brain development. Histochem Cell Biol (2017) 0.80

Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy. Pediatr Blood Cancer (2014) 0.78

mRNA deadenylation and telomere disease. J Clin Invest (2015) 0.78

Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide. Int J Mol Sci (2014) 0.77

TeloPIN: a database of telomeric proteins interaction network in mammalian cells. Database (Oxford) (2015) 0.77

Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells. Toxicol Sci (2016) 0.76

Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome. Int J Mol Sci (2015) 0.76

Reverse Expression of Aging-Associated Molecules through Transfection of miRNAs to Aged Mice. Mol Ther Nucleic Acids (2016) 0.75

Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases. Mod Pathol (2017) 0.75

Association between regulator of telomere elongation helicase 1 polymorphism and susceptibility to glioma. Int J Clin Exp Med (2015) 0.75

Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition. Front Oncol (2017) 0.75

Articles cited by this

(truncated to the top 100)

Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20

Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97

Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48

Telomere measurement by quantitative PCR. Nucleic Acids Res (2002) 18.69

Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19

A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 12.55

Telomerase catalytic subunit homologs from fission yeast and human. Science (1997) 12.35

Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A (1988) 11.81

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74

The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95

A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell (2004) 6.48

Structure and variability of human chromosome ends. Mol Cell Biol (1990) 6.18

Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell (2009) 5.74

Current concepts in the pathophysiology and treatment of aplastic anemia. Blood (2006) 5.20

Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00

Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell (1997) 4.86

Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol (1998) 4.59

Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57

Cancer in dyskeratosis congenita. Blood (2009) 4.28

TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12

Association between aplastic anaemia and mutations in telomerase RNA. Lancet (2002) 4.02

Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc (2006) 4.00

Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86

Telomere length and risk of incident cancer and cancer mortality. JAMA (2010) 3.55

A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science (2009) 3.34

The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29

Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2005) 3.12

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02

RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell (2009) 2.93

Removal of shelterin reveals the telomere end-protection problem. Science (2012) 2.87

Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol (2000) 2.78

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76

TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell (2012) 2.74

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood (2003) 2.73

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet (2013) 2.62

Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol Cell (2009) 2.62

Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61

Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One (2011) 2.61

Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60

Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45

Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44

Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43

Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature (2012) 2.33

RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell (2012) 2.24

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood (2010) 2.16

CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer (2012) 2.14

Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10

Progressive telomere shortening in aplastic anemia. Blood (1998) 2.10

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood (2007) 2.02

TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99

Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98

Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell (2010) 1.97

Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood (2001) 1.89

Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA (2010) 1.86

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol (1999) 1.84

The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82

The human CST complex is a terminator of telomerase activity. Nature (2012) 1.81

Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res (2011) 1.79

Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77

Telomeric 3' overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell (2012) 1.77

Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin Genet (2011) 1.74

Analysis of telomeres in peripheral blood cells from patients with bone marrow failure. Pediatr Blood Cancer (2009) 1.71

CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J (2012) 1.65

Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat Res (2011) 1.56

Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am J Hum Genet (2012) 1.54

Human CST promotes telomere duplex replication and general replication restart after fork stalling. EMBO J (2012) 1.47

Specificity requirements for human telomere protein interaction with telomerase holoenzyme. J Biol Chem (2012) 1.47

Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica (2012) 1.45

Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet (1992) 1.40

It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res (2011) 1.36

Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35

Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument. Neuropediatrics (2004) 1.29

Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatr Scand (1970) 1.29

Human CST has independent functions during telomere duplex replication and C-strand fill-in. Cell Rep (2012) 1.29

Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol (1999) 1.26

A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood (1996) 1.24

A role for heterochromatin protein 1γ at human telomeres. Genes Dev (2011) 1.22

Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21

A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand (1988) 1.18

Bilateral coats retinopathy associated with aplastic anaemia and mild dyskeratotic signs. Am J Med Genet (1994) 1.16

Telomere length changes in patients with aplastic anaemia. Br J Haematol (2001) 1.15

Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Crit Rev Oncol Hematol (2008) 1.12

Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol Cell Biol (2004) 1.08

Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. Am J Hum Genet (2012) 1.07

Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. Ann N Y Acad Sci (2009) 1.05

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood (2008) 1.04

Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. Exp Hematol (2006) 1.03

Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita. Blood (2012) 0.99

Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. Br J Haematol (2003) 0.99

Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs. Hum Mol Genet (2009) 0.97

Accelerated telomere shortening in Fanconi anemia fibroblasts--a longitudinal study. FEBS Lett (2001) 0.94

Telomere dysfunction and its role in haematological cancer. Br J Haematol (2012) 0.93

Articles by these authors

The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83

Distinct faces of the Ku heterodimer mediate DNA repair and telomeric functions. Nat Struct Mol Biol (2007) 1.55

Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35

A role for heterochromatin protein 1γ at human telomeres. Genes Dev (2011) 1.22

Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet (2005) 1.19

Segregating YKU80 and TLC1 alleles underlying natural variation in telomere properties in wild yeast. PLoS Genet (2009) 1.14

Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leuk Lymphoma (2012) 1.13

Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. Mol Cancer Ther (2009) 1.11

Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer (2009) 1.01

Ku must load directly onto the chromosome end in order to mediate its telomeric functions. PLoS Genet (2011) 0.94

Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis--an entity different from adults. Am J Hematol (2012) 0.94

TRF2 interaction with Ku heterotetramerization interface gives insight into c-NHEJ prevention at human telomeres. Cell Rep (2013) 0.87

Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J Clin Immunol (2014) 0.86

The association of yKu with subtelomeric core X sequences prevents recombination involving telomeric sequences. Genetics (2009) 0.85

A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome. Blood (2013) 0.83

Regulation of Ku-DNA association by Yku70 C-terminal tail and SUMO modification. J Biol Chem (2014) 0.82

The role of telomeres and telomerase in cancer research. Cancer Res (2010) 0.82

Abdominal undifferentiated small round cell tumor with unique translocation (X;19)(q13;q13.3). Pediatr Blood Cancer (2010) 0.82

An S/T-Q cluster domain census unveils new putative targets under Tel1/Mec1 control. BMC Genomics (2012) 0.81

Ku's essential role in keeping telomeres intact. Proc Natl Acad Sci U S A (2009) 0.80

Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys (2008) 0.79

Measuring relative telomere length: is tissue an issue? Aging (Albany NY) (2010) 0.79

Modeling growth and telomere dynamics in Saccharomyces cerevisiae. J Theor Biol (2009) 0.77